These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33889468)

  • 1. A Case of Severe Metabolic Acidosis due to Jardiance-Induced Euglycemic Diabetic Ketoacidosis.
    Dyatlova N; Omotosho YB; Sherchan R; Shrestha J; Buddharaju V
    Cureus; 2021 Apr; 13(4):e14580. PubMed ID: 33889468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Unsuspected Case of Euglycemic Diabetic Ketoacidosis With Twists.
    Kang CY; Khamooshi P; Reyes Pinzon V
    Cureus; 2022 Apr; 14(4):e24016. PubMed ID: 35573514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic.
    Ozer O; Yorulmaz G
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):110-111. PubMed ID: 33115581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports.
    Altowayan WM
    Ann Med Surg (Lond); 2022 Dec; 84():104879. PubMed ID: 36582864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: High-Calorie Glucose Infusion and Tight Glycemic Control in Ameliorating Refractory Acidosis of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis.
    Wan Azman SS; Sukor N; Abu Shamsi MY; Ismail I; Kamaruddin NA
    Front Endocrinol (Lausanne); 2022; 13():867647. PubMed ID: 35712244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip.
    Zughaib MT; Patel K; Leka M; Affas S
    Cureus; 2022 Jan; 14(1):e21768. PubMed ID: 35251838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors be avoided in Covid-19 and other acute Infections?
    Pilianidis G; Papanastasiou G; Tikoudi P; Themistocleous A; Farmakis G; Dolianitis K
    Eur J Case Rep Intern Med; 2024; 11(3):004282. PubMed ID: 38455692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk of Euglycemic Diabetic Ketoacidosis Due to Low-carbohydrate Diet While Taking Empagliflozin: a Case Report].
    Yamamoto M; Ide N; Kitajima S; Obayashi M; Asada K; Matsushima S; Ito M
    Yakugaku Zasshi; 2019; 139(11):1479-1483. PubMed ID: 31685745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Significance of Precise Diabetes Diagnosis: A Case of Euglycemic Diabetic Ketoacidosis Induced by the Introduction of Empagliflozin with Simultaneous Reduction of Insulin Dosage.
    Bińczyk W; Dróżdż O; Siudek B; Głuszczyk AM; Plizga JI; Grajnert FJ
    Eur J Case Rep Intern Med; 2024; 11(6):004567. PubMed ID: 38846667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis Masked by Urinary Tract Infection.
    Chauhan S; Diaz V; Ogbu IR; Sanchez JRP; Manov AE; Shah P
    Cureus; 2024 Aug; 16(8):e66408. PubMed ID: 39246944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old.
    Petersen C; Gyabaah F; Sotelo J; Yohanna S; Deoker A
    Cureus; 2023 Sep; 15(9):e45180. PubMed ID: 37842482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Euglycemic Diabetic Ketoacidosis, Recurrent Genital Abscess, and Proximal Renal Tubular Acidosis With Concurrent SGLT-2 Inhibitor: More Than an Association.
    Alshaakh Moh'd Mari A; Iwuagwu CC; Johnson M
    Cureus; 2024 Aug; 16(8):e67481. PubMed ID: 39310404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-surgical Euglycemic Diabetic Ketoacidosis in a Patient on Empagliflozin in the Intensive Care Unit.
    Bteich F; Daher G; Kapoor A; Charbek E; Kamel G
    Cureus; 2019 Apr; 11(4):e4496. PubMed ID: 31259114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report.
    Batista DV; Vieira CAFA; Costa TA; Lima EG
    Diabetol Int; 2021 Jul; 12(3):313-316. PubMed ID: 33133998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery.
    Osafehinti DA; Okoli OJ; Karam JG
    AACE Clin Case Rep; 2021; 7(1):20-22. PubMed ID: 33851014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postop Complication With Euglycemic Diabetic Ketoacidosis in a Patient Receiving Empagliflozin.
    Fustiga J; Fernandes M; Dâmaso F; Duarte JA; Rodrigues C
    Cureus; 2022 Dec; 14(12):e33161. PubMed ID: 36726923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports.
    Juneja D; Nasa P; Jain R; Singh O
    World J Diabetes; 2023 Aug; 14(8):1314-1322. PubMed ID: 37664476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium-glucose co-transporter 2 inhibitors induced euglycemic diabetic ketoacidosis within four days of initiation.
    Razok A; Ata F; Ahmed SMI; Al Mohanadi DHSH
    World J Diabetes; 2022 Mar; 13(3):272-274. PubMed ID: 35432760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium-Glucose Co-transporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Bariatric Surgery: A Case and Literature Review.
    Kapila V; Topf J
    Cureus; 2021 Aug; 13(8):e17093. PubMed ID: 34527480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and management.
    Long B; Lentz S; Koyfman A; Gottlieb M
    Am J Emerg Med; 2021 Jun; 44():157-160. PubMed ID: 33626481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.